Skip to main content
NeuronFeed
/ STARTUPS

All AI startups

61 startups tracked. Filter by category, country, funding stage, or whether they have an active deal.

SORT
On this page
25
of 61 total
Funding (page)
$7.3B
combined raised
Avg score
66
0 verified · 0 with deal
More filters
Reset

Isomorphic Labs

London-based AI drug-design company spun out of Google DeepMind to reimagine the entire drug

Drug Discovery
Raised
$2.7B
Stage
S-B
90

Generate:Biomedicines

PRIVATE
United States est. 2018

Generative AI for programmable protein therapeutics

AI HealthcareDrug Discovery
Raised
$700M
Stage
S-C
77

Proscia

United States est. 2014

AI-powered digital pathology for precision medicine

AI HealthcareDrug Discovery
Raised
$130M
Stage
S-D
75

Genesis Therapeutics

AI drug-discovery company building generative and predictive models to design small-molecule

Drug Discovery
Raised
$344M
Stage
STRATEGIC EQUITY INVESTMENT
72

Aqemia

French AI drug-discovery company that fuses quantum-inspired statistical mechanics with deep

Drug Discovery
Raised
$103M
Stage
S-B
71

Tahoe Therapeutics

Tahoe Therapeutics, formerly Vevo Therapeutics, builds gigascale single-cell datasets to train

Drug Discovery
Raised
$30M
Stage
S-A
69

Cellular Intelligence

United States

Foundation models for human stem cells to industrialize cell therapy production

Foundation ModelsDrug Discovery
Raised
$47M
Stage
S-A
69

Chemify

United Kingdom est. 2022

Digitizing chemistry with AI and robotics to make any molecule on demand

Drug DiscoveryAI Robotics
Raised
$93M
Stage
S-B
69

Accipiter Biosciences

United States est. 2025

AI-designed de novo protein therapies for complex diseases

AI HealthcareDrug Discovery
Raised
$12.7M
Stage
Seed
68

Yoneda Labs

United States est. 2023

Foundation AI model for chemistry

Foundation ModelsDrug Discovery
Raised
$4M
Stage
Seed
67

Axiom Bio

United States est. 2023

AI models that predict human drug toxicity without animal testing

AI MedicalDrug Discovery
Raised
$15M
Stage
Seed
67

Recursion

United States est. 2013

Pioneering AI-driven solutions in drug discovery to radically improve lives.

AI HealthcareDrug Discovery
Raised
$500M
Stage
IPO
66

Alchemab Therapeutics

UK biotech using machine learning to mine patient-derived immune responses for protective

Drug Discovery
Raised
$32M
Stage
S-A
66

Paradigm Health

United States est. 2023

AI research platform making clinical trials part of routine patient care

AI HealthcareDrug Discovery
Raised
$359M
Stage
S-B
65

Adaptyv Bio

Switzerland

Cloud lab that experimentally validates AI-designed proteins in under three weeks

Drug DiscoveryAI Robotics
Raised
$8M
Stage
Seed
64

Treeline Biosciences

United States est. 2021

Computational and experimental drug discovery for hard-to-drug cancer targets

AI MedicalDrug Discovery
Raised
$1.1B
Stage
S-A
63

Ollin Biosciences

Biotech advancing best-in-class bispecific antibody therapies for eye disease, using AI and

Drug Discovery
Raised
$100M
Stage
S-A
60

Lindus Health

United Kingdom est. 2021

The anti-CRO running radically faster, AI-enabled clinical trials end to end

AI HealthcareDrug Discovery
Raised
$78M
Stage
S-B
59

Edison Scientific

United States est. 2025

AI scientist that compresses months of research into a single day

Research AssistantsDrug Discovery
Raised
$70M
Stage
Seed
59

Bioptimus

France est. 2024

Building the first universal AI foundation model for biology.

Foundation ModelsDrug Discovery
Raised
$76M
Stage
S-A
58

Ensocell

Cambridge, UK biotech that integrates single-cell and spatial genomics with AI to discover

Drug Discovery
Raised
$16.3M
Stage
Seed
58

Genesis Molecular AI

United States est. 2019

Generative AI for small-molecule drug discovery

AI HealthcareDrug Discovery
Raised
$280M
Stage
S-B
57

Manas AI

United States est. 2024

AI-driven discovery of novel cancer medicines

Drug Discovery
Raised
$24.6M
Stage
Seed
57

Pathos AI

est. 2022

Patient-centric, AI-powered drug development company focused on accelerating cancer therapies

Drug Discovery
Raised
$467M
Stage
S-D
57

Diffuse Bio

United States

Generative AI for protein design with in-house assay development and data generation

Foundation ModelsDrug Discovery
57